II-mGluR |
group II metabotropic glutamate receptors |
III-mGluR |
group III metabotropic glutamate receptors |
5-HT |
serotonin |
5-HT2AR |
serotonin receptor type 2A |
5-HT7R |
serotonin receptor type 7 |
ACTH |
adrenocorticotropic hormone |
AMPA |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
AMPAR |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/glutamate receptor |
BDNF |
brain-derived neurotrophic factor |
DRN |
dorsal raphe nucleus |
Erk |
extracellular Signal-regulated Kinase |
EMA |
the European Medicines Agency |
FDA |
the Food and Drug Administration |
fMRI |
functional magnetic resonance imaging |
GABA |
γ-aminobutyrate |
LC |
locus coeruleus |
MDTN |
mediodorsal thalamic nucleus |
MK801 |
dizocilpine |
mTOR |
mammalian target of rapamycin |
NMDAR |
N-methyl-D-aspartate/glutamate receptor |
OFC |
orbitofrontal cortex |
PPI |
prepulse inhibition |
RTN |
reticular thalamic nucleus |
SNRI |
serotonin norepinephrine reuptake inhibitor |
SSRI |
selective serotonin reuptake inhibitor |
VTA |
ventral tegmental area |